Home/ Supplements/ Berberine/ Berberine X5

Berberine X5

product on market Capsule InnovaPharm Essentials Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Berberine X5
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
90
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

GlucoVantage
100 mg

Other Ingredients

Rice, Powder Vegetable Capsule Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

1 capsule before carbs Suggested use: Take 1 capsule, 15-30 minutes before carbohydrate containing meals. Use up to 3 capsules daily.

Warnings & Precautions

Warning: This product is only to be consumed by healthy adults, 18 years of age or older.

If you are pregnant, breast feeding, have known medical conditions (including but not limited to: kidney, liver or heart disease) or are taking prescription or OTC medication(s), consult with your health care practitioner before using this product.

Discontinue use two weeks prior to surgery.

Keep out of reach of children.

Allergen Information: Not manufactured with wheat, gluten, soy, fish, shellfish, egg, milk or tree nut ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Formulation Notes

Vegan + Non-GMO + Gluten free

Vegan + Non-GMO + Gluten free

Allergen Information: Not manufactured with wheat, gluten, soy, fish, shellfish, egg, milk or tree nut ingredients.

Dihydroberberine Includes: GlucoVantage

Promotes insulin sensitivity Healthy blood sugar support

Advanced berberine metabolite

Additional Information

Manufactured in a U.S. GMP Facility

Instagram Facebook Follow us: @InnovaPharm

Metadata

Product Details

UPC / SKU6 36946 25160 4
DSLD Entry Date2023-09-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID299145
Data Updated2026-04-11
Research

Research Evidence

98
Research Sources
55
Avg Quality
48
Systematic Review
39
Meta Analysis
4
Rct
4
Clinical Trial
1
Other
1
Narrative Review
1
Openfda Safety
B Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2018 PubMed DOI
B Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Clinical nutrition ESPEN 2022 PubMed DOI
B Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 PubMed DOI
B Effect of Berberine on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2019 PubMed DOI
B Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta Analysis The Journal of nutrition 2023 PubMed DOI
B The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
Meta Analysis Journal of translational medicine 2024 PubMed DOI
B Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Systematic Review International journal of molecular sciences 2024 PubMed DOI
B Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis The American journal of Chinese medicine 2019 PubMed DOI
B Effects of Berries, Phytochemicals, and Probiotics on Atherosclerosis through Gut Microbiota Modification: A Meta-Analysis of Animal Studies
Meta Analysis International journal of molecular sciences 2023 PubMed DOI
B Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical Trial
Rct JAMA network open 2025 PubMed DOI
View all evidence for Berberine →
Compare

Similar Products

View all Berberine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.